INVESTIGATION OF RISTOCETIN-INDUCED PLATELET AGGREGATION, PARAMETERS OF VON WILLEBRAND FACTOR AND THE COAGULATION FACTOR VIII AT ESSENTIAL ARTERIAL HYPERTENSION IN CHILDREN

INVESTIGATION OF RISTOCETIN-INDUCED PLATELET AGGREGATION, PARAMETERS OF VON WILLEBRAND FACTOR AND THE COAGULATION FACTOR VIII AT ESSENTIAL ARTERIAL HYPERTENSION IN CHILDREN

Ristocetin-induced platelet aggregation, von Willebrand factor and coagulation factor VIII of 170 children with essential arterial hypertension and 40 healthy children were investigated. Burdened hereditary thrombotic history, increase of ristocetin-induced platelet aggregation, activity and content...

Full description

Bibliographic Details
Main Author:	M. V. Gomellya
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2014-02-01
Series:	Acta Biomedica Scientifica
Subjects:	platelet aggregation von willebrand factor coagulation factor viii arterial hypertension in children
Online Access:	https://www.actabiomedica.ru/jour/article/view/1706

Similar Items

The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V
by: Juan A. De Pablo-Moreno, et al.
Published: (2022-07-01)

von Willebrand Disease: The diagnosis and management of this bleeding disorder
by: Basim A. Abd, et al.
Published: (2020-01-01)

Polyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitro
by: Marcela Montilla, et al.
Published: (2022-11-01)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
by: Castaman G, et al.
Published: (2016-06-01)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
by: Gritsch H, et al.
Published: (2022-11-01)

Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population
by: Zongkui Wang, et al.
Published: (2017-03-01)

Desmopressin testing in von Willebrand disease: Lowering the burden
by: Jessica M. Heijdra, et al.
Published: (2022-08-01)

[Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease]
by: Giancarlo Castaman
Published: (2016-06-01)

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow
by: Hiroaki Yaoi, et al.
Published: (2023-12-01)

Increased von Willebrand and Factor VIII plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID
by: Stefania Bellone, et al.
Published: (2024-02-01)

Mutations in Coagulation Factor VIII Are Associated with More Favorable Outcome in Patients with Cutaneous Melanoma
by: Zheng Ping, et al.
Published: (2017-07-01)

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease
by: Michelle Sholzberg, et al.
Published: (2021-07-01)

Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
by: Bauer A, et al.
Published: (2023-06-01)

Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure
by: Pamela A. Christopherson, et al.
Published: (2022-10-01)

Von Willebrand factor levels in healthy blood donors and their association with blood group: A tertiary care hospital-based study
by: Nikita Agrawal, et al.
Published: (2023-01-01)

Von Willebrand Factor Multimeric Assay in Acquired von Willebrand Disease Diagnosis: A Report of Experience from North Estonia Medical Centre
by: Marika Pikta, et al.
Published: (2021-06-01)

The Molecular Genetics of von Willebrand Disease
by: Ergül Berber
Published: (2012-12-01)

A novel approach to laboratory assessment and reporting of platelet von Willebrand factor
by: Thorsten Kragh, et al.
Published: (2022-02-01)

Elevated Factor VIII and von Willebrand Factor Levels Predict Unfavorable Outcome in Stroke Patients Treated with Intravenous Thrombolysis
by: Noémi Klára Tóth, et al.
Published: (2018-01-01)

Genetic Variants Identified by Whole Exome Sequencing in a Large Italian Family with High Plasma Levels of Factor VIII and Von Willebrand Factor
by: Silvia Spena, et al.
Published: (2023-09-01)

GENÉTICA MOLECULAR DE LA HEMOFILIA A EN UNA FAMILIA COLOMBIANA CON DIAGNÓSTICO DE ENFERMEDAD DE VON WILLEBRAND Y DE HEMOFILIA A
by: Diana Carolina Polanía Villanueva, et al.
Published: (2014-12-01)

Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
by: Daniel Simon, et al.
Published: (2003-12-01)

Quantitative 3D microscopy highlights altered von Willebrand factor α‐granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms
by: Maurice Swinkels, et al.
Published: (2021-08-01)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2018-01-01)

Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia
by: Monica Sacco, et al.
Published: (2020-03-01)

Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices
by: Ulrich Geisen, et al.
Published: (2018-01-01)

Púrpura trombocitopênica trombótica: o papel do fator von Willebrand e da ADAMTS13 Thrombotic thrombocytopenic purpura: the role of von Willebrand factor and ADAMTS13
by: Leandro C. Tonaco, et al.
Published: (2010-01-01)

Soluble P-Selectin and von Willebrand Factor Rise in Healthy Volunteers Following Non-exertional Ascent to High Altitude
by: Helena A. Turton, et al.
Published: (2022-02-01)

Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)
by: Auerswald G, et al.
Published: (2020-06-01)

Establishing reference intervals for von Willebrand factor multimers
by: Pikta Marika, et al.
Published: (2022-01-01)

Age-Associated Increase in Thrombogenicity and Its Correlation with von Willebrand Factor
by: Parnian Alavi, et al.
Published: (2021-09-01)

Clinical Application of Factor VIII:C to VWF:Ag Ratio for the Screening of Haemophilia A Carriers
by: Ki-Young Yoo, et al.
Published: (2022-03-01)

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
by: Ingrid Skornova, et al.
Published: (2021-11-01)

Physical Characteristics of von Willebrand Factor Binding with Platelet Glycoprotein Ibɑ Mutants at Residue 233 Causing Various Biological Functions
by: Masamitsu Nakayama, et al.
Published: (2022-10-01)

Platelet adhesion on commercially pure titanium plates in vitro I: effects of plasma components and involvement of the von Willebrand factor and fibronectin
by: Akira Takahashi, et al.
Published: (2019-02-01)

Frequency Assessment of the H817Q (2451T→A) Variant of von Willebrand Gene in Individuals without Hemorrhagic Signs
by: Mansoureh Bakhtiari, et al.
Published: (2016-08-01)

Patient with von Willebrand Disease for Gynaecologic Surgery - Perianaesthetic Concerns
by: Rakesh Garg, et al.
Published: (2008-01-01)

Plasma Clearance of Coagulation Factor VIII and Extension of Its Half-Life for the Therapy of Hemophilia A: A Critical Review of the Current State of Research and Practice
by: Andrey G. Sarafanov
Published: (2023-05-01)

Platelets compensate for poor thrombin generation in type 3 von Willebrand disease
by: Timea Szanto, et al.
Published: (2020-01-01)

Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation
by: Alexandre Mansour, et al.
Published: (2020-07-01)